首页> 美国卫生研究院文献>Oncology Letters >MicroRNA-195 inhibits the behavior of cervical cancer tumors by directly targeting HDGF
【2h】

MicroRNA-195 inhibits the behavior of cervical cancer tumors by directly targeting HDGF

机译:MicroRNA-195通过直接靶向HDGF抑制宫颈癌肿瘤的行为

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

MicroRNAs (miRNAs/miRs) are a class of conserved non-coding endogenous small regulatory RNAs that regulate target gene expression by binding to the 3′-untranslated region of target mRNAs in a base-pairing manner, resulting in repression of transcription or degradation of target mRNAs. It has been demonstrated previously that the abnormal expression of miRNAs is involved in the carcinogenesis and progression of cervical cancer. The aim of the present study was to investigate the expression, biological functions and underlying molecular mechanisms of miR-195 in cervical cancer. The reverse transcription-quantitative polymerase chain reaction (RT-qPCR) was used to detect the expression level of miR-195 in cervical cancer tissues and cell lines. Following transfection, an MTT assay, cell migration and invasion assays, western blot analysis and a dual-luciferase reporter assay were performed in human cervical cancer cells. In the present study, it was identified that miR-195 was downregulated in cervical cancer tissues and cell lines. Additionally, upregulation of miR-195 and knockdown of hepatoma-derived growth factor (HDGF) inhibited proliferation, migration and invasion of cervical cancer cells. Furthermore, a dual-luciferase reporter assay identified that HDGF was a direct target gene of miR-195. RT-qPCR and western blot analysis demonstrated that miR-195 mimic inhibited HDGF expression at the mRNA and protein levels, whereas miR-195 inhibitor enhanced HDGF expression at the mRNA and protein levels. These results indicated that miR-195 targeted HDGF to inhibit the behavior of tumors in cervical cancer. These results also suggested that miR-195 was a potential therapeutic biomarker of cervical cancer.
机译:MicroRNA(miRNA / miRs)是一类保守的非编码内源性小调节RNA,它们通过以碱基配对的方式与靶mRNA的3'-非翻译区结合来调节靶基因的表达,从而导致转录的抑制或降解。靶mRNA。先前已证明,miRNA的异常表达与宫颈癌的发生和发展有关。本研究的目的是研究miR-195在宫颈癌中的表达,生物学功能和潜在的分子机制。逆转录定量聚合酶链反应(RT-qPCR)用于检测miR-195在宫颈癌组织和细胞系中的表达水平。转染后,在人宫颈癌细胞中进行了MTT测定,细胞迁移和侵袭测定,蛋白质印迹分析和双重荧光素酶报告基因测定。在本研究中,已确定miR-195在宫颈癌组织和细胞系中被下调。此外,miR-195的上调和肝癌衍生的生长因子(HDGF)的抑制可抑制子宫颈癌细胞的增殖,迁移和侵袭。此外,双荧光素酶报告基因测定法鉴定出HDGF是miR-195的直接靶基因。 RT-qPCR和蛋白质印迹分析表明,miR-195模仿物在mRNA和蛋白质水平抑制HDGF的表达,而miR-195抑制剂在mRNA和蛋白质水平抑制HDGF的表达。这些结果表明,miR-195靶向HDGF以抑制子宫颈癌中的肿瘤行为。这些结果还表明,miR-195是宫颈癌的潜在治疗生物标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号